抑制类风湿关节炎炎症:患者整体评估是否模糊了治疗目标?基于临床实践的范式转变呼吁
这项横断面单中心研究纳入309例连续门诊类风湿关节炎(RA)患者,按ACR/EULAR布尔标准分为缓解、近缓解(仅PGA>1)和非缓解。近缓解患者疾病活动度与缓解者无差异,但疾病影响与非缓解者相似;PGA主要由疲劳、疼痛、焦虑和功能解释,与疾病活动度指标无关。提示PGA主要反映疾病影响而非炎症,建议临床实践区分炎症缓解和疾病影响两个独立目标。
要点
- 近缓解患者仅PGA>1,其疾病活动度与缓解者无差异但疾病影响与非缓解者相似。
- PGA主要由疲劳、疼痛、焦虑和功能解释(R²adjusted=0.50),疲劳和疼痛与疾病活动度指标无关。
- 建议临床实践以两个独立目标为指导:炎症缓解(3v-remission)和疾病影响。
核心结论
- 在RA中,共识可接受的疾病活动度水平(SJC28、TJC28和CRP≤1)不等同于低疾病影响,很大比例患者仅因PGA被归为非缓解。
- PGA主要反映疲劳、疼痛、功能和心理领域,不足以定义免疫抑制治疗的目标。
- 临床实践应以两个独立缓解目标为指导:炎症(3v-remission)和疾病影响。
研究设计与样本
- 横断面单中心研究,纳入连续门诊RA患者309例。
- 收集肿胀28关节计数(SJC28)、压痛28关节计数(TJC28)、C反应蛋白(CRP)、PGA、疼痛、疲劳、功能、焦虑、抑郁、幸福感、人格特质和合并症等数据。
- 按ACR/EULAR布尔标准分类缓解:缓解、近缓解(仅PGA>1)和非缓解,并研究无PGA的二元定义(3v-remission)。
- 采用单变量和多变量分析识别各缓解状态下PGA的解释变量。
主要发现
- 309例患者中缓解占9.4%,近缓解占37.2%,非缓解占53.4%。
- 近缓解患者与缓解者在疾病活动度上无法区分,但描述的疾病影响与非缓解者相似。
- 多变量分析中,近缓解患者的PGA由疲劳、疼痛、焦虑和功能解释(R²adjusted=0.50)。
- 疲劳和疼痛与疾病活动度指标无关系。
关键数值与推荐
- 缓解分类采用ACR/EULAR布尔标准:缓解、近缓解(仅PGA>1)和非缓解。
- 研究还采用无PGA的二元定义(3v-remission)。
临床怎么用
- 临床实践应以两个独立目标为指导:炎症缓解(3v-remission)和疾病影响。
- 对于仅PGA升高的近缓解患者,需评估疲劳、疼痛、功能和心理领域,而非强化免疫抑制治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In current management paradigms of rheumatoid arthritis (RA), patient global assessment (PGA) is crucial to decide whether a patient has attained remission (target) or needs reinforced therapy. We investigated whether the clinical and psychological determinants of PGA are appropriate to support this important role. METHODS: This was a cross-sectional, single-center study including consecutive ambulatory RA patients. Data collection comprised swollen 28-joint count (SJC28), tender 28-joint count (TJC28), C-reactive protein (CRP) level, PGA, pain, fatigue, function, anxiety, depression, happiness, personality traits, and comorbidities. Remission was categorized using American College of Rheumatology/European League Against Rheumatism Boolean-based criteria: remission, near-remission (only PGA >1), and nonremission. A binary definition without PGA (3v-remission) was also studied. Univariable and multivariable analyses were used to identify explanatory variables of PGA in each remission state. RESULTS: A total of 309 patients were included (remission 9.4%, near-remission 37.2%, and nonremission 53.4%). Patients in near-remission were indistinguishable from remission regarding disease activity, but described a disease impact similar to those in nonremission. In multivariable analyses, PGA in near-remission was explained (R2adjusted = 0.50) by fatigue, pain, anxiety, and function. Fatigue and pain had no relationship with disease activity measures. CONCLUSION: In RA, a consensually acceptable level of disease activity (SJC28, TJC28, and CRP level ≤1) does not equate to low disease impact: a large proportion of these patients are considered in nonremission solely due to PGA. PGA mainly reflects fatigue, pain, function, and psychological domains, which are inadequate to define the target for immunosuppressive therapy. This consideration suggests that clinical practice should be guided by 2 separate remission targets: inflammation (3v-remission) and disease impact.
引用
- Ferreira RJO, Duarte C, Ndosi M, et al. Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice-Based Call for a Paradigm Change. Arthritis Care Res (Hoboken). 2018. PMID: 28544615. doi:10.1002/acr.23284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。